AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr | ₹586 Cr |
What is the latest Total Non-Current Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹1,462 Cr |
Mar2023 | ₹1,246 Cr |
Mar2022 | ₹1,153 Cr |
Mar2021 | ₹685 Cr |
Mar2020 | ₹586 Cr |
How is Total Non-Current Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,462 Cr | 17.35 | |
Mar2023 | ₹1,246 Cr | 8.11 | |
Mar2022 | ₹1,153 Cr | 68.24 | |
Mar2021 | ₹685 Cr | 16.92 | |
Mar2020 | ₹586 Cr | - |
Compare Total Non-Current Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AKUMS DRUGS & PHARMACEUTICALS | ₹8,078.6 Cr | -0.9% | 7.9% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AKUMS DRUGS & PHARMACEUTICALS | -0.9% |
7.9% |
|
SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses